Shanna A. Arnold - Concepedia

Author

Shanna A. Arnold

The University of Texas Southwestern Medical Center

Also Known As

S ARNOLD, Shanna A Arnold, Shanna A. Arnold, Shanna Arnold, Sven Arnold

Publications

995

Citations

H-Index

Concepts

All Affiliations

The University of Texas Southwestern Medical Center Vanderbilt University Medical Center Vanderbilt University Medical University of South Carolina

About

Shanna A. Arnold is an author at The University of Texas Southwestern Medical Center specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	671
2	Cell Biology	8	8	626
3	Immunology	2	2	178
4	Biochemistry	1	1	18
5	Obstetrics	1	1	18

Shanna A. Arnold

Publications

830

Citations

H-Index

Page 1

	Year	Citations
SPARC: a matricellular regulator of tumorigenesis Shanna A. Arnold, Rolf A. Brekken Journal of Cell Communication and Signaling OncologyMalignant DiseaseMedicineImmune ModulationCancer Growth	2009	174
Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products Fredrick D. Oakley, Marcella C. Woods, Shanna A. Arnold, Transfusion	2014	145
Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma Shanna A. Arnold, Lee B. Rivera, Andrew F. Miller, Disease Models & Mechanisms Tumor BiologySubcutaneous Tumor ModelsPancreatic CancerImmunologyOrthotopic Murine Model	2009	111
ALCAM/CD166 Is a TGF-β–Responsive Marker and Functional Regulator of Prostate Cancer Metastasis to Bone Amanda G. Hansen, Shanna A. Arnold, Ming Jiang, Cancer Research Cell Adhesion MoleculeCell AdhesionPathologySheddase Adam17Cancer Biology	2014	84
Losartan Slows Pancreatic Tumor Progression and Extends Survival of SPARC-Null Mice by Abrogating Aberrant TGFβ Activation Shanna A. Arnold, Lee B. Rivera, Juliet G. Carbon, PLoS ONE Active Tgfβ1Biological MicroenvironmentsPathologyTumor BiologyTgfβ1 Expression	2012	75
Forced Expression of MMP9 Rescues the Loss of Angiogenesis and Abrogates Metastasis of Pancreatic Tumors Triggered by the Absence of Host SPARC Shanna A. Arnold, E. Mira, Sabeeha Muneer, Experimental Biology and Medicine OncologyPancreatic CancerMedicineMmp9 InteractImmunology	2008	67
Integrin-Free Tetraspanin CD151 Can Inhibit Tumor Cell Motility upon Clustering and Is a Clinical Indicator of Prostate Cancer Progression Trenis D. Palmer, Carlos H. Martínez, Catalina Vásquez, Cancer Research Cancer BiologyTumor BiologyClinical IndicatorGenitourinary CancerCancer Cell Biology	2013	58
Elevated ALCAM Shedding in Colorectal Cancer Correlates with Poor Patient Outcome Amanda G. Hansen, Tanner J. Freeman, Shanna A. Arnold, Cancer Research Molecular BiomarkersTumor BiologyPrognostic BiomarkersMedicineCell Adhesion	2013	39
Urinary oncofetal ED-A fibronectin correlates with poor prognosis in patients with bladder cancer Shanna A. Arnold, Holli A. Loomans‐Kropp, Tatiana Ketova, Clinical & Experimental Metastasis Urological ResearchUrologyTumoral PathologyGenitourinary CancerMedicine	2015	26
MAGI-2 in prostate cancer: an immunohistochemical study Alexander D. Borowsky, Rajen Goyal, Joseph T. Roland, Human Pathology MedicineUrologyTumor BiologyProstatic Disease	2016	19

Page 1